<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Uganda offers a unique setting in which to study the effect of human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus-1 (HIV-1) on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>HIV-1 is prevalent there, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> which are known to be HIV-associated, such as <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, are endemic </plain></SENT>
<SENT sid="2" pm="."><plain>Adults residing in Kampala, Uganda, presenting with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in city hospitals were interviewed and had an HIV test </plain></SENT>
<SENT sid="3" pm="."><plain>Of the 302 adults recruited, 190 had <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> with a potentially infectious aetiology (cases) </plain></SENT>
<SENT sid="4" pm="."><plain>The remaining 112 adults with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> not known to have an infectious aetiology formed the control group </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, 318 children who were also Kampala residents were recruited and tested for HIV: 128 with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (cases) and 190 with non-malignant conditions (controls) </plain></SENT>
<SENT sid="6" pm="."><plain>HIV seroprevalence was 24% in adult controls and 6% in childhood controls </plain></SENT>
<SENT sid="7" pm="."><plain>The odds of HIV seropositivity among cases with specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (other than <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> in adults) were compared with that among controls, using odds ratios (ORs), estimated with unconditional logistic regression </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> ORs were adjusted for age (&lt;5, 5-14, 15-19, 30-44, 45+) and sex and, in adults, also for the number of lifetime sexual partners (1 or 2, 3-9, 10+) </plain></SENT>
<SENT sid="9" pm="."><plain>In adults, <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> was associated with a significantly (p &lt; 0.05) increased risk of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [OR = 6.2, 95% confidence interval (CI) 1.9-19.9, based on 21 cases] and conjunctival <z:hpo ids='HP_0002860'>squamous-cell carcinoma</z:hpo> (OR = 10.9, 95% CI 3.1-37.7, based on 22 cases) but not with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> at other common sites, including liver and uterine cervix </plain></SENT>
<SENT sid="10" pm="."><plain>In children, <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> was associated with a significantly increased risk of <z:hpo ids='HP_0100726'>Kaposi's sarcoma</z:hpo> (OR = 94.9, 95% CI 28.5-315.3, based on 36 cases) and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (OR = 7.5, 95% CI 2.8-20.1, based on 33 cases) but not with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>The pattern of HIV-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> in Uganda is broadly similar to that described elsewhere, but the relative frequency of specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, such as conjunctival <z:mp ids='MP_0002038'>carcinoma</z:mp>, in HIV-infected people differs </plain></SENT>
</text></document>